Patent · US Active

Fused ring compounds

US11760744B2 · kind B2 · utility

0Cited by

1References

28Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Aijun Lu · Beijing, CN
Sushant Malhotra · South San Francisco, US
Alan G. Olivero · South San Francisco, US
Cheng SHAO · Beijing, CN
Yamin Zhang · Miaocheng, CN
Steven Do · San Jose, US

Key dates

Filing date	Aug 15, 2019
Grant date	Sep 19, 2023
Priority date	—
Expiry date	Aug 15, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are fused ring compounds of Formula (I), Formula (II), or Formula (III), as further detailed herein, which are used for the inhibition of Ras proteins, as well as compositions comprising these compounds and methods treatment by their administration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.